#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2410777	B	Inhibition of human ERK2 pre-incubation for 15 mins before substrate addition measured after 60 mins by IMAP-FP assay	Homo sapiens	3		single protein format	Scientific Literature
2.	ALA2410778	B	Inhibition of mouse ERK2 pre-incubation for 15 mins before substrate addition measured after 60 mins by IMAP-FP assay	Mus musculus	3		single protein format	Scientific Literature
3.	ALA3706036	B	IMAP-FP Assay: Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was determined from a 10 point (1:3 serial dilution, 3 uM starting compound concentration) titration curve using the following outlined procedure. To each well of a black Corning 384-well plate (Corning Catalog #3575), 7.5 mL of compound (3333 fold dilution in final assay volume of 25 uL) was dispensed, followed by the addition of 15 uL of kinase buffer (tween containing kinase buffer, Molecular Devices) containing 0.0133 ng/mL (0.316 nM) of phosphorylated active mERK2 enzyme. Following a 15 minute compound & enzyme incubation, each reaction was initiated by the addition of 10 uL kinase buffer containing 2.45 uM ERK2 IMAP substrate peptides (2.25 uM-unlabeled IPTTPITTTYFFFK-COOH and 200 nM-labeled IPTTPITTTYFFFK-5FAM (5-carboxyfluorescein)-COOH), and 75 uM ATP.	Mus musculus	24		single protein format	BindingDB Database
4.	ALA3706037	B	IMAP-FP Assay: Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was determined from a 10 point (1:3 serial dilution, 3 uM starting compound concentration) titration curve using the following outlined procedure. To each well of a black Corning 384-well plate (Corning Catalog #3575), 7.5 mL of compound (3333 fold dilution in final assay volume of 25 uL) was dispensed, followed by the addition of 15 uL of kinase buffer (tween containing kinase buffer, Molecular Devices) containing 0.0364 ng/mL (0.833 nM) of phosphorylated active hERK2 enzyme. Following a 15 minute compound & enzyme incubation, each reaction was initiated by the addition of 10 uL kinase buffer containing 2.45 uM ERK2 IMAP substrate peptides (2.25 uM-unlabeled IPTTPITTTYFFFK-COOH and 200 nM-labeled IPTTPITTTYFFFK-5FAM (5-carboxyfluorescein)-COOH), and 75 uM ATP.	Homo sapiens	641		single protein format	BindingDB Database
5.	ALA4426443	B	Selectivity ratio, ratio of IC50 for human ERK2 to IC50 for MEK1 (unknown origin)	Homo sapiens	1		assay format	Scientific Literature
6.	ALA4426444	B	Selectivity ratio, ratio of IC50 for human ERK2 to IC50 for RAF1 (unknown origin)	Homo sapiens	1		assay format	Scientific Literature
7.	ALA4426447	B	Inhibition of human ERK2 preincubated for 15 mins followed by addition of IMAP peptide substrate and ATP measured after 60 mins by IMAP-FP assay	Homo sapiens	21		single protein format	Scientific Literature
8.	ALA4426452	B	Inhibition of mouse ERK2 preincubated for 15 mins followed by addition of IMAP peptide substrate and ATP measured after 60 mins by IMAP-FP assay	Mus musculus	10		single protein format	Scientific Literature
9.	ALA4426453	B	Inhibition of ERK in human A375SM cells harboring BRAF V600E mutant assessed as inhibition of RSK phosphorylation measured after 4 hrs by mesoscale electrochemiluminescent sandwich assay	Homo sapiens	13		cell-based format	Scientific Literature
10.	ALA4426490	B	Selectivity ratio, ratio of IC50 for human ERK2 to IC50 for COT (unknown origin)	Homo sapiens	1		assay format	Scientific Literature
11.	ALA4426491	B	Selectivity ratio, ratio of IC50 for human ERK2 to IC50 for BRAF (unknown origin)	Homo sapiens	1		assay format	Scientific Literature